Cantor Fitzgerald Reiterates Overweight on Upexi, Maintains $2 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 67.8%

Neg 0% Neu 67.8% Pos 0%

Cantor Fitzgerald analyst Gareth Gacetta reiterates Upexi (NASDAQ:UPXI) with a Overweight and maintains $2 price target.